Asthma Inhaler Device Market: Information by Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices), End User (Hospitals & Clinics, Homecare) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2030

Asthma Inhaler Device Market Overview

Based on the research, the Asthma Inhaler Device Market is expected to grow at a CAGR of 6.42% during the forecast period. The market is also expected to reach a revenue of USD 19677.54 million by the end of 2022-2030. 

Asthma, the chronic lung disease, is responsible for narrowing down and inflaming the airways. Problems like coughing, sneezing, tightness in the chest, difficulty breathing and shortness of breath are associated with asthma. asthma inhaler assistance devices are hand-held machines to treat such breathing problems. These machines are mainly used to treat or prevent diseases associated with the airways.

This report covers all the driving factor proving boost to the market growth. It also highlights many prominent key players of the market and what strategies they are adopting in order to sustain the high level of competition of the Asthma Inhaler Device Market. Post covid-19 scenario of the market and the market segmentations along with its regional analysis have been covered in the report.

Covid-19 impact

Although covid-19 has impacted most of the industries negatively, but it has also positive impact on some the few industries. Asthma Inhaler Device Market is one of such industries. A high amount of population was already suffering from asthma and covid-19 had made the situation even worse. As breathing problem is considered as one of the major symptoms of covid-19, it only increased the number of people suffering from breathing trouble.

Market dynamics

Drivers

Asthma Inhaler Device Market is expected to grow during the forecast period due to the rising cases of asthma. The prevalence of asthma in children and rising awareness among people are also increasing the demand for metered dose inhalers. This demands and rising awareness of asthma among people are driving the growth of the market.

Opportunities

Many prominent key players investing in research and development along with new product launches and collaborating with other players of the market are going to create a huge number of opportunities in the Asthma Inhaler Device Market.

Cumulative growth

In 2019, the retail pharmacies segment had the largest share of the Asthma Inhaler Device Market. North America had the largest market share of Asthma Inhaler in 2019.

Segmentation overview

Based on the global market, the Asthma Inhaler Device Market is segmented into-

• Type


• Mode of operation


• End-User


• Region

By Type

Based on type, the Asthma Inhaler Device Market is further segmented into-

• Metered Dose Inhalers


• Standard Pressurized Metered-Dose Inhalers


• Breath-Actuated Pressurized Metered-Dose Inhalers


• Metered-Dose Inhaler with a Spacer


• Dry Powder Inhalers


• Soft Mist Inhalers

By Mode of operation

Based on mode of operation, the Asthma Inhaler Device Market is further segmented into-

• Manually Operated Inhaler Devices


• Digitally Operated Inhaler Devices

By End-User

Based on end-user, the Asthma Inhaler Device Market is further segmented into-

• Hospitals and Clinics


• Homecare


• Others

By Region

Based on region, the Asthma Inhaler Device Market is further segmented into-

• Americas




• North America




• US


• Canada




• Latin America

• Europe




• Western Europe




• Germany


• UK


• France


• Italy


• Spain


• Rest of Western Europe




• Eastern Europe

• Asia-Pacific




• Japan


• China


• India


• Australia


• South Korea


• Rest of Asia-Pacific

• Middle East & Africa




• Middle East


• Africa

Regional analysis

The regional Asthma Inhaler Device Market is broadly divided into the Americas, Europe, Asia-Pacific and the MEA.

Among all these regional markets, America is expected to be the most dominating region due to the increasing cases of asthma in the region. The rising demand for metered-dose inhaler and smart inhalers along with the technological advancements are providing a boost to the American Asthma Inhaler Device Market. Europe is expected to be the second largest region of the Asthma Inhaler Device Market during the forecast period. European Academy of Allergy & Clinical Immunology is making constant efforts to make people aware of the problem. The rising awareness among people and hospitals and patients adopting respiratory inhalers are driving the growth of the European market. In Asia-Pacific regional market is growing due to the rising prevalence of asthma in countries like India, china and Japan. The MEA is also expecting a steady growth because of the rising cases of asthma and demand  for better treatment.

Competitive landscape

The global Asthma Inhaler Device Market is highly competitive with the presence of many prominent key players in the market. To sustain in the completion of the market, the key players are embracing various strategies such as collaboration with other players, partnership, product launch, merger and acquisition and investment in research and developments.

Major key players

• GlaxoSmithKline plc (UK)


• Koninklijke Philips NV (Netherlands)


• AstraZeneca (UK)


• Cipla Inc. (India)


• Boehringer Ingelheim International GmbH (Germany)


• Beximco Pharmaceuticals Ltd (Bangladesh)


• Merck & Co., Inc. (the US)


• Teva Pharmaceutical Industries Ltd (Israel)


• Chiesi Farmaceutici SpA (Italy)


• and Medisol Lifescience Pvt. Ltd (India).

Report Overview

The report comprises of

• Market overview


• Covid-19 impact


• Market dynamics


• Drivers


• Challenges


• Restrains


• Opportunities


• Technological analysis


• Segmentation overview


• Regional analysis


• Competitive landscape


• Recent developments


• Major key players